116 related articles for article (PubMed ID: 19225990)
1. A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).
Ikenouchi-Sugita A; Yoshimura R; Hayashi K; Ueda N; Umene-Nakano W; Hori H; Nakamura J
World J Biol Psychiatry; 2009; 10(4 Pt 3):977-80. PubMed ID: 19225990
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
[TBL] [Abstract][Full Text] [Related]
3. [Aripiprazole for the treatment of Tourette's syndrome].
Stenstrøm AD; Sindø I
Ugeskr Laeger; 2008 Jan; 170(1):58. PubMed ID: 18208720
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole for the treatment of adolescent Tourette's syndrome: a case report.
Lewis K; Rappa L; Sherwood-Jachimowicz DA; Larose-Pierre M
J Pharm Pract; 2010 Jun; 23(3):239-44. PubMed ID: 21507820
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole is effective in the treatment of Tourette's disorder.
Constant EL; Borras L; Seghers A
Int J Neuropsychopharmacol; 2006 Dec; 9(6):773-4. PubMed ID: 16734937
[No Abstract] [Full Text] [Related]
7. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
Lyon GJ; Samar S; Jummani R; Hirsch S; Spirgel A; Goldman R; Coffey BJ
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of aripiprazole in children and adolescents with Tourette's disorder.
Yoo HK; Kim JY; Kim CY
J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):505-6. PubMed ID: 16958578
[No Abstract] [Full Text] [Related]
9. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.
Yoo HK; Joung YS; Lee JS; Song DH; Lee YS; Kim JW; Kim BN; Cho SC
J Clin Psychiatry; 2013 Aug; 74(8):e772-80. PubMed ID: 24021518
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.
Budman C; Coffey BJ; Shechter R; Schrock M; Wieland N; Spirgel A; Simon E
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):509-15. PubMed ID: 18928415
[TBL] [Abstract][Full Text] [Related]
11. Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Yoshimura R; Ueda N; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):256-61. PubMed ID: 20218790
[TBL] [Abstract][Full Text] [Related]
12. A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole.
Davies L; Stern JS; Agrawal N; Robertson MM
Hum Psychopharmacol; 2006 Oct; 21(7):447-53. PubMed ID: 17029306
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tics in tourette syndrome with aripiprazole.
Kastrup A; Schlotter W; Plewnia C; Bartels M
J Clin Psychopharmacol; 2005 Feb; 25(1):94-6. PubMed ID: 15643108
[No Abstract] [Full Text] [Related]
14. Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.
Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Hayashi K; Atake K; Tomita M; Nakamura J
Hum Psychopharmacol; 2012 Jan; 27(1):33-8. PubMed ID: 22213405
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole in patients with Tourette syndrome.
Bubl E; Perlov E; Tebartz Van Elst L
World J Biol Psychiatry; 2006; 7(2):123-5. PubMed ID: 16684686
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.
Seo WS; Sung HM; Sea HS; Bai DS
J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):197-205. PubMed ID: 18439116
[TBL] [Abstract][Full Text] [Related]
17. Case series on the use of aripiprazole for Tourette syndrome.
Murphy TK; Bengtson MA; Soto O; Edge PJ; Sajid MW; Shapira N; Yang M
Int J Neuropsychopharmacol; 2005 Sep; 8(3):489-90. PubMed ID: 15857570
[No Abstract] [Full Text] [Related]
18. Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients.
Wenzel C; Kleimann A; Bokemeyer S; Müller-Vahl KR
J Clin Psychopharmacol; 2012 Aug; 32(4):548-50. PubMed ID: 22722499
[TBL] [Abstract][Full Text] [Related]
19. [Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients].
Miranda C M; Castiglioni T C
Rev Med Chil; 2007 Jun; 135(6):773-6. PubMed ID: 17728905
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a clozapine-aripiprazole combination in Tourette syndrome and bipolar spectrum disorder.
Piccinni A; Veltri A; Marazziti D; Moroni I; Dell'Osso L
J Neuropsychiatry Clin Neurosci; 2013; 25(1):E45. PubMed ID: 23487230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
